Pentasa Sachets licensed for paediatric use

on the 28 June 2010

Pentasa Sachets (mesalazine) are now licensed for use in children with mild to moderate ulcerative colitis, from the age of 6 years.

As a general rule, half the adult dose may be given to children up to a body weight of 40kg, and the normal adult dose to those weighing more than 40kg.

Pentasa Sachets were previously contraindicated under the age of 12 years. The only other mesalazine preparation currently available for use in children is Salofalk Granules.

View Pentasa drug record

Further information: Ferring Pharmaceuticals

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

The most up-to-date drug information at your fingertips.

  • Get the prescribing support you need.
  • Register today for full access to the MIMS database, plus tables and guideline summaries, new and deleted products and consultation tools.
Register Now
Already Registered?

Forgotten password?

MIMS Clinics

Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.

Twitter  

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more